Fund HoldingsCommodore Capital LP

Total Portfolio Value
$1.42B
Total Bought
$334.90M
Total Sold
$270.34M
Net Transaction
+$64.56M
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
PROTAGONIST THERAPEUTICS INC01,075,000+1,075,000059,4154.19%+59,415
CIDARA THERAPEUTICS INC01,175,000+1,175,000057,2344.04%+57,234
RELAY THERAPEUTICS INC(RLAY)013,350,000+13,350,000046,1913.26%+46,191
KYMERA THERAPEUTICS INC(KYMR)0750,000+750,000032,7302.31%+32,730
TYRA BIOSCIENCES INC(TYRA)950,0003,100,000+2,150,0008,83529,6672.09%+20,832
VIRIDIAN THERAPEUTICS INC(VRDN)3,600,0004,875,000+1,275,00048,52868,1534.81%+19,625
CYTOMX THERAPEUTICS INC07,692,300+7,692,300017,4621.23%+17,462
XENON PHARMACEUTICALS INC(XENE)2,325,0003,025,000+700,00078,00494,6836.68%+16,679
AGIOS PHARMACEUTICALS INC(AGIO)2,185,0002,325,000+140,00064,02177,3305.46%+13,309
CELLDEX THERAPEUTICS INC NEW(CLDX)3,200,0003,450,000+250,00058,08070,2084.96%+12,128
CENTESSA PHARMACEUTICALS PLC2,367,5783,298,289+930,71134,04643,3403.06%+9,294
TANGO THERAPEUTICS INC(TNGX)01,500,000+1,500,00007,6800.54%+7,680
CRESCENT BIOPHARMA INC.0453,686+453,68607,3220.52%+7,322
MIND MEDICINE MINDMED INC4,525,0005,000,000+475,00026,47132,4502.29%+5,979
ALKERMES PLC(ALKS)1,950,0002,450,000+500,00064,38970,0954.95%+5,706
PHARVARIS N V
COM
1,911,4331,911,433030,00933,6412.37%+3,632
ENLIVEN THERAPEUTICS INC4,675,0004,692,809+17,80992,00494,1386.64%+2,134
APOGEE THERAPEUTICS INC(APGE)290,000290,000010,83412,5950.89%+1,760
ORUKA THERAPEUTICS INC(ORKA)1,419,7141,419,714014,56615,9151.12%+1,349
PERCEPTIVE CAP SOLUTIONS COR
CL A ORD SHS
750,000750,00007,7257,9650.56%+240
VISTAGEN THERAPEUTICS INC1,575,0001,575,00003,9383,1500.22%-787
INHIBIKASE THERAPEUTICS INC5,344,4325,397,488+53,05611,70410,5250.74%-1,179
AVALO THERAPEUTICS INC(AVTX)483,000483,00003,8692,4100.17%-1,459
NURIX THERAPEUTICS INC(NRIX)3,978,9073,948,653-30,25447,26944,9753.17%-2,294
SPYRE THERAPEUTICS INC(SYRE)1,988,0841,988,084032,07829,7622.10%-2,316
MERUS N V4,472,8403,525,000-947,840188,262185,41513.09%-2,847
NEUROGENE INC925,000427,866-497,13410,8326,3970.45%-4,435
SCHOLAR ROCK HLDG CORP(SRRK)1,745,0001,450,000-295,00056,10251,3593.63%-4,743
BRIGHT MINDS BIOSCIENCES INC500,000500,000018,03513,0550.92%-4,980
CELCUITY INC(CELC)695,6500-695,6507,0330-7,033
ORIC PHARMACEUTICALS INC(ORIC)2,000,0000-2,000,00011,1600-11,160
CARDIFF ONCOLOGY INC5,384,6160-5,384,61616,9080-16,908
SOLID BIOSCIENCES INC5,825,0000-5,825,00021,5530-21,552
NUVALENT INC(NUVL)1,855,0001,375,000-480,000131,557104,9137.41%-26,644
SOLENO THERAPEUTICS INC1,150,000610,000-540,00082,16851,1063.61%-31,062
COGENT BIOSCIENCES INC(COGT)8,892,8162,311,164-6,581,65253,26816,5941.17%-36,674
VERA THERAPEUTICS INC(VERA)2,561,782800,000-1,761,78261,53418,8481.33%-42,686
VAXCYTE INC(PCVX)1,650,0000-1,650,00062,3040-62,304
Page 1 of 1